CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ...

CAMBRIDGE, UK & BILLERICA, Mass. — Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ink technology, ...

Drug developers are consistently aiming to enhance clinical relevance in drug discovery. CRISPR has emerged as a versatile tool to accelerate the entire drug discovery process, with arrayed CRISPR ...

Amidst the crackle of cellular signaling, it can be hard to distinguish between cells that are quick on the draw, and those that take a long time “drawing a bead” before they finally fire. When the ...

(Nanowerk Spotlight) For decades, microfluidics has held promise as a revolutionary technology, yet widespread adoption outside research labs has remained elusive. Microfluidic devices enable precise ...

UK-based biotech firm Nuclera has announced it has acquired Taiwan-based E Ink Holdings (EIH)'s digital microfluidics unit to form its US subsidiary. Combining the technologies of the two companies ...

Oak Brook, IL – The February 2023 issue of SLAS Technology contains a set of four original research articles and one review article covering digital microfluidics (DMF), cryopreservation, colorectal ...

Digital SPR TM is a next-generation technology for characterizing biomolecular interactions. By combining digital microfluidics (DMF) with SPR, digital SPR systems can effectively bypass common ...